Sunday, September 16, 2012 10:38:40 PM
Company raises full-year 2012 production guidance; oil/liquids volumes now expected to increase nearly 30% over prior year
http://www.newfield.com/assets/pdf/2Q12%20Ops%20Presentation.pdf
I stand corrected they are shifting into oil but my friend is still drilling for gas and has the last 15yrs for NFX
I think he is in the eagle Ford shale area in south Texas
http://eaglefordshale.com/drilling-rig-count/
Our shift to oil, which began in 2009, continues as more than half of our expected production in the second half of 2012 will be oil/liquids. For 2012, we expect our oil/liquids production will increase nearly 30% over 2011 levels. Our liquids production today is largely 'black oil'. With the strength of our performance year-to-date, we are again revising our full-year 2012 production expectations higher. Our focus today is clear: grow oil production, grow cash flow and position our Company for strong performance in 2013."
Newfield's oil and liquids liftings in the second quarter of 2012 were 6.1 MMBbls (67,000 BOPD) and comprised 49% of total Company production. Approximately 4% of Newfield's second quarter production was NGLs. Second quarter 2012 oil/liquids volumes were 40% higher than in the comparable period of 2011. Natural gas production in the second quarter of 2012 was approximately 40 Bcf, or an average of approximately 440 MMcf/d. On an equivalent basis, Newfield's production in the second quarter of 2012 was 76.4 Bcfe.
For the second time this year, Newfield raised its 2012 expectations for total Company production to 296 – 304 Bcfe (previous guidance was 292 – 302 Bcfe). With increasing activities planned in key oil regions in late 2012 and ongoing leasing in the Cana Woodford, Newfield expects that its capital investments in 2012 will approximate $1.7 billion, or the "upper end" of its original guidance range of $1.5 – $1.7 billion.
Recent NFX News
- Rainbow Rare Earth highlights assessment at Uberaba • Alliance News • 03/12/2026 01:25:11 AM
- Nuformix PLC £1.0 million Placing • RNS Regulatory News • 03/11/2026 07:00:07 AM
- Cloudcoco's "transformative" year; CEPS pays debt • Alliance News • 03/10/2026 04:34:29 PM
- Nuformix Secures U.S. Orphan Drug Designation for IPF Therapy Candidate NXP002 • UK Market News • 03/10/2026 08:22:59 AM
- Nuformix PLC Confirmation of US ODD for NXP002 in IPF • RNS Regulatory News • 03/10/2026 07:00:11 AM
- Nuformix PLC Result of AGM • RNS Regulatory News • 03/03/2026 10:05:00 AM
- Nuformix PLC Posting of Annual Report and Notice of AGM • RNS Regulatory News • 02/05/2026 12:00:01 PM
- Nuformix focused on lead asset for pulmonary fibrosis as loss narrows • Alliance News • 01/27/2026 02:23:24 PM
- Nuformix PLC Annual Results for period ended 30 September 2025 • RNS Regulatory News • 01/27/2026 07:00:07 AM
- Nuformix PLC Total Voting Rights • RNS Regulatory News • 11/28/2025 03:22:23 PM
- Nuformix raises GBP228,000 in open offer • Alliance News • 11/12/2025 04:59:02 PM
- Celsius raises funds; Built Cybernetics acquisition • Alliance News • 11/12/2025 03:40:10 PM
- Nuformix Awaits FDA Feedback on Orphan Drug Status for IPF Therapy • UK Market News • 11/12/2025 08:28:10 AM
- *Nuformix to issue 114.0m shares at 0.2p for gross proceeds GBP228,081 • Alliance News • 11/12/2025 07:46:33 AM
- Nuformix PLC Update re. US FDA ODD Application • RNS Regulatory News • 11/12/2025 07:01:00 AM
- Nuformix PLC Results of Underwritten Open Offer • RNS Regulatory News • 11/12/2025 07:00:09 AM
- Nuformix launches £228,081 open offer to accelerate fibrosis and oncology programs • UK Market News • 10/28/2025 08:30:52 AM
- Nuformix PLC Underwritten Open Offer • RNS Regulatory News • 10/28/2025 07:00:08 AM
- Nuformix Appoints New Auditor as Part of Strategic Progress • UK Market News • 10/10/2025 07:12:35 AM
- Nuformix PLC Change of Auditor • RNS Regulatory News • 10/10/2025 06:00:10 AM
- Nuformix PLC European Respiratory Society Congress Attendance • RNS Non-Regulatory • 09/25/2025 06:00:13 AM
- Nuformix submits FDA drug designation application for NXP002 • Alliance News • 08/11/2025 11:11:14 AM
- Nuformix PLC US FDA ODD Application Submitted for NXP002 • RNS Regulatory News • 08/11/2025 06:00:09 AM
- Nuformix PLC Total Voting Rights • RNS Regulatory News • 05/30/2025 01:24:44 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM

